Tag: Guokang Ruijin Pharmaceutical
Record China pharma monopoly fine a deterrent, says expert
China issues record pharma fine, targeting firms and individual for monopoly violations
China issues record pharma fine, targeting firms and individual for monopoly violations
Draft Advocates Amendment Bill 2026 could formalise law firms, mandate registration and admit foreign practices
91视频 senior advocate designation forces partners to leave firms, but reforms may allow continued affiliation
Follow us on LinkedIn